Showing all 9 results
Efavirenz Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the highly lipophilic active ingredient.
Active Ingredient Strength Primary Clinical Function Efavirenz USP/Ph.Eur. 600 mg The Global NNRTI Macrodose: The massive therapeutic payload required to force immediate, systemic viral suppression when combined with a dual-NRTI backbone. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Surfactant / Binder / Heavy Film-Coating (Engineered specifically utilizing powerful surfactants like Sodium Lauryl Sulfate to drastically increase the solubility of the notoriously lipophilic Efavirenz molecule, ensuring rapid and complete gastrointestinal absorption) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for massive NGO distribution and chronic daily dispensing regimens).
FLUCONAZOLE & IVERMECTIN TABLETS
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Fluconazole USP/Ph.Eur. 150 mg The Antifungal Anchor (Macro-Dose): The foundational triazole payload required to systematically eradicate widespread dermatophytes and yeasts. Ivermectin EP/USP 6 mg / 12 mg The Antiparasitic Assassin (Micro-Dose): The highly potent, targeted neurotoxin required to paralyze burrowing mites, lice, and severe helminthic infections. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / High-Shear Binder / Glidant / Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the lethal 6mg micro-dose of Ivermectin is flawlessly distributed throughout the massive Fluconazole matrix, preventing toxic “hot spots”) *Pack Sizes: Single-Dose Blister Packs (1×1 or 1×2) or 10×10 Blisters (Optimized specifically for rapid NGO deployment and “stat” dosing protocols).
Gefitinib tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the targeted antineoplastic agent.
Active Ingredient Strength Primary Clinical Function Gefitinib USP/Ph.Eur. 250 mg Global Adult Oncology Standard: The definitive, highly precise daily maintenance dose required to maintain constant, paralyzing pressure on the mutated EGFR protein to keep the lung cancer in deep molecular remission. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to maximize the dissolution of this poorly soluble compound while locking the cytotoxic API safely inside the tablet, completely preventing handler and pharmacist exposure to the carcinogenic dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Naltrexone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Taste-Masked Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Naltrexone Hydrochloride USP/Ph.Eur. 50 mg Global Addiction Standard: Single daily maintenance dose to ensure continuous, 24-hour blockade of opioid receptors and suppression of alcohol cravings. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Crospovidone / Magnesium Stearate / Colloidal Silicon Dioxide / Premium Opadry Film Diluent / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically to completely mask the violently bitter taste of the API, preventing the patient from spitting the pill out and ensuring total compliance) *Pack Sizes: 10×10 Blisters or Bottles of 30/100 (Optimized specifically for strictly monitored, 30-day outpatient rehabilitation dispensing regimens).
Nicotinic acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute physical stability of the extended-release polymer.
Active Ingredient Strength Primary Clinical Function Nicotinic Acid (Niacin) USP/Ph.Eur. 500 mg (ER) Initiation / Titration Standard: Base therapeutic unit for the mandatory, slow 4-week dose titration protocol required to build patient tolerance. Nicotinic Acid (Niacin) USP/Ph.Eur. 1000 mg (ER) Global Cardiology Standard: High-dose adult maintenance therapy for severe mixed dyslipidemia and extreme hypertriglyceridemia. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Stearic Acid / Colloidal Silicon Dioxide / Premium Opadry Film Hydrophilic Polymer Matrix / Diluent / Lubricant / Glidant (Engineered specifically to form a viscous, highly controlled gel barrier upon swallowing, metering the API release precisely into the gastrointestinal tract over 8-12 hours) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict chronic cardiology dispensing regimens).
Nimesulide ,Paracetamol & Chlorzoxazone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of all three active ingredients.
Active Ingredient Strength Primary Clinical Function Nimesulide BP/Ph.Eur. 100 mg Preferential COX-2 NSAID: Rapid abortion of localized musculoskeletal inflammation and tissue swelling. Paracetamol (Acetaminophen) BP/Ph.Eur. 325 mg Central Analgesic: Synergistic pain threshold elevation and antipyretic control. Chlorzoxazone USP/Ph.Eur. 250 mg Central Muscle Relaxant: Direct inhibition of spinal reflex arcs to break severe, locked muscle spasms. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder / Moisture-Barrier Coating (Engineered specifically to trigger a violent, immediate structural collapse in the stomach, ensuring all three APIs are absorbed simultaneously for synchronized relief) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, short-term acute dispensing to ensure patients do not exceed the mandated 15-day Nimesulide therapy limit).
Nimesulide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active ingredient.
Active Ingredient Strength Primary Clinical Function Nimesulide BP/Ph.Eur. 100 mg Global Acute Standard: High-efficacy adult therapeutic unit for the rapid, short-term abortion of acute inflammatory pain. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Docusate Sodium / Povidone K30 / Magnesium Stearate Diluent / Superdisintegrant / Wetting Surfactant / Binder (Engineered specifically to trigger a violent, immediate structural collapse in the stomach, maximizing the drug’s surface area for ultra-fast gastrointestinal absorption) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, short-term acute dispensing to ensure patients do not exceed the mandated 15-day therapy limit).
Nimesulide,Paracetamol & Serratiopeptidase Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Multi-Particulate Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly delicate enzyme component.
Active Ingredient Strength Primary Clinical Function Nimesulide BP/Ph.Eur. 100 mg Preferential COX-2 NSAID: Rapid abortion of localized musculoskeletal inflammation and tissue pain. Paracetamol (Acetaminophen) BP/Ph.Eur. 325 mg Central Analgesic: Synergistic pain threshold elevation and antipyretic control. Serratiopeptidase (as Enteric-Coated Granules) 15 mg
(Equivalent to 30,000 Serratiopeptidase Units)Proteolytic Enzyme: Direct breakdown of fibrin and inflammatory exudate to physically drain severe localized edema. Excipients Methacrylic Acid Copolymer / Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Magnesium Stearate Enteric Polymer Shield / Diluent / Superdisintegrant / Binder (Engineered specifically to protect the enzyme from gastric acid while allowing the analgesics to dissolve instantly in the stomach) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, short-term acute dispensing to ensure patients do not exceed the mandated 15-day Nimesulide therapy limit).
Pazopanib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, High-Density Film-Coated Tablet, packed exclusively in highly secure, child-resistant heavy-gauge HDPE bottles or specialized Alu-Alu blister strips to ensure the absolute chemical stability of the cytotoxic molecule and prevent accidental exposure.
Active Ingredient Strength Primary Clinical Function Pazopanib HCl INN/Ph.Eur. 200 mg (Base Equivalent) Dose-Modification Standard: Essential unit for precise dose reduction in patients experiencing severe hepatic toxicity or adverse drug reactions. Pazopanib HCl INN/Ph.Eur. 400 mg (Base Equivalent) Global Clinical Standard: Primary therapeutic unit designed to achieve the massive 800 mg daily protocol with minimal pill burden. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K30 / Magnesium Stearate / Hypromellose / Titanium Dioxide Diluent / Superdisintegrant / Binder / Lubricant / Premium Cytotoxic-Barrier Film-Coating (Engineered specifically to seal the lethal HPAPI inside the tablet, completely protecting healthcare workers and caregivers from highly toxic dust exposure) *Pack Sizes: Bottles of 30 or 60 Tablets (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
